| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5709062 | The Journal of Arthroplasty | 2017 | 9 Pages |
Abstract
Patients with hematologic malignancies undergoing THA have an increased risk of perioperative complications, longer LOS, and higher costs. The risk quantification for adverse perioperative outcomes in association with increased cost may help to design different risk stratification and reimbursement methods in such populations.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Jared M. MD, Jaiben MBBS, W. Trevor MD, Suparna M. MS, MPH, Alison K. MS, Wael K. MD, Carlos A. MD,